Sarah Carpenter

Statistics

Publications

Citations

213

H-Index

Active since

1989

Affiliations

Elusys Therapeutics (United States)(Current)

Battelle

Duke Medical Center

Sarah Carpenter is an author at Elusys Therapeutics (United States) specializing in pharmacology, immunology of infectious diseases, and immunopharmacology.

Publications per year

1989–2017

Publications

Vancomycin-associated linear IgA dermatosis

Sarah Carpenter, Daniel Berg, Navjeet Sidhu‐Malik et al. · Journal of the American Academy of Dermatology · 1992 · 82 citations

Medicine, Dermatology, Immunology +10

Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax

Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy · 2016 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

Brent Yamamoto, Annette M. Shadiack, Sarah Carpenter et al. · Antimicrobial Agents and Chemotherapy · 2016 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies

Christa F. Nagy, Timothy Leach, Joseph H. Hoffman et al. · Clinical Therapeutics · 2016 · 22 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

Lisa N. Henning, Sarah Carpenter, Gregory V. Stark et al. · Antimicrobial Agents and Chemotherapy · 2017 · 18 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +16

1–5 of 6